Progestin-Only Pill Use and Breastfeeding Study

• Status: Recruiting
• Trial end date: 2022-06-30
• Target enrollment: 0
• Participant gender: Female

Summary

This study will assess the impact of early initiation (less than one week postpartum) and delayed initiation (4 weeks postpartum) of two types of progestin-only contraceptive pills (POPs) on maternal, breastmilk, and infant outcomes.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of California, San Diego
• Treatments: Contraceptive Agents; Progestins

Criteria

Inclusion Criteria:

• 13 years of age and older

• Desires to use POPs for 3 months

• Speak English or Spanish

• Had a vaginal or cesarean delivery of a singleton full term (≥37 weeks) infant less than 168 hours prior

• Intends to breastfeed exclusively for 6 months

Exclusion Criteria:

• Desire another pregnancy in less than 6 months

• Do not intend to exclusively breastfeed

• Do not have access to a telephone

• Have any medical contraindication to POPs

• Have any contraindication to breastfeeding, including maternal illegal drug use, history of augmentation or reduction, infant with major congenital anomaly

• Cognitively impaired

• Currently incarcerated